We serve Chemical Name:Amino(3-cyclohexen-1-yl)acetic acid CAS:23364-04-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Amino(3-cyclohexen-1-yl)acetic acid
CAS.NO:23364-04-7
Synonyms:Amino-cyclohex-3-enyl-essigsaeure;Cyclohexen-3-ylglycine;amino-cyclohex-3-enyl-acetic acid;EINECS 245-614-1;3-Cyclohexene-1-acetic acid, α-amino-;3-Cyclohexenylglycin;3-Cyclohexenylglycine;Amino(3-cyclohexen-1-yl)acetic acid
Molecular Formula:C8H13NO2
Molecular Weight:155.194
HS Code:2922499990
Physical and Chemical Properties:
Melting point:N/A
Boiling point:294.7±23.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.535
PSA:63.32000
Exact Mass:155.094635
LogP:1.10
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Amino-cyclohex-3-enyl-essigsaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Amino(3-cyclohexen-1-yl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Cyclohexenylglycine Use and application,3-Cyclohexene-1-acetic acid, α-amino- technical grade,usp/ep/jp grade.
Related News: McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 2,6-diaminohex-4-enoic acid manufacturers The all-in-one platform provides access to specialists in the fields of leadership, diversity, inclusion and belonging, sleep, nutrition, parenting, and more – to optimize and accelerate personal growth and professional development in support of a person’s whole health, at work and in life. 5-methyl-2-n-propyl-4-imidazolecarboxaldehyde suppliers Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). N,N’-bis-(2-cyano-ethyl)-thiourea vendor & factory.
